About this document
Ebc 68 Ebc20240024 by Robert Stryjak is a document available to read on EtoBox.
This review article discusses the impact of phage-specific antibodies on the efficacy of phage therapy, particularly in the context of increasing antibiotic resistance. It highlights that while phage therapy shows promise, the generation of antibodies against phages can lead to their rapid clearance and reduced antibacterial activity, complicating clinical outcomes. The authors summarize recent findings on antibody production during phage therapy and suggest strategies to improve treatment regimens by consi
- Author
- Robert Stryjak
- Language
- EN